HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

DHC

Diversified Healthcare Trust

Real Estate — REIT - Healthcare Facilities

Diversified Healthcare Trust is a real estate investment trust focused on owning high-quality healthcare properties located throughout the United States. DHC seeks diversification across the health services spectrum by care delivery and practice type, by scientific research disciplines and by property type and location. As of March 31, 2026, DHC's approximately 6.2 billion dollars portfolio included 285 properties in 33 states and Washington, D.C., with 23,901 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group, a leading U.S. alternative asset management company with over 37 billion dollars in assets under management as of March 31, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquarters in Newton, MA. Diversified Healthcare Trust was incorporated in 1998 in Maryland.

Buy 2.0 / 5 4 analysts
$7.74
$-0.11 (-1.40%)
Target: $9.88 (27.6%)

Price History

52-Week Range
Sign in to add DHC to a watchlist or set price alerts.

Fundamentals

Market Cap$2.24B
P/E Ratio (TTM)-
Forward P/E-19.45
EPS (TTM)$-1.33
Dividend Yield0.43%
Profit Margin-21.10%
Revenue Growth-5.30%
ROE-17.94%
Debt/Equity149.23
Recommendation Buy 2.0
Analyst Target$9.88
Analysts4
Next Earnings Aug 3, 2026 AMC
Indexes -

Technical Indicators

RSI (14)58.7
Beta2.29
SMA 20-
SMA 40-
52-Week High$9.66
52-Week Low$3.18
50-Day Avg$8.49
200-Day Avg$6.24
Avg Volume$1.78M
Volume$1.23M

Performance Analysis

BULLISH

DHC shows predominantly bullish signals based on its fundamentals and technicals.

+ Showing strength at 70% of its 52-week range.
+ RSI at 58.7 shows positive momentum.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
- Revenue declined 5.3% year-over-year.
- Operating at a loss with -21.1% margin.
+ Wall Street consensus is "Buy" from 4 analysts.
+ Average analyst target of $9.88 implies 27.6% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:06 UTC

Back to Screener Export Report